Dr. Saag has received consultant fees, speaking fees, and/or honoraria (less than $10,000 each) from Merck, Lilly, Novartis, P&G, Aventis, Genentech, Takeda, AstraZeneca, and Horizon.
Article first published online: 30 MAR 2011
Copyright © 2011 by the American College of Rheumatology
Arthritis Care & Research
Volume 63, Issue 4, pages 465–482, April 2011
How to Cite
Beukelman, T., Patkar, N. M., Saag, K. G., Tolleson-Rinehart, S., Cron, R. Q., DeWitt, E. M., Ilowite, N. T., Kimura, Y., Laxer, R. M., Lovell, D. J., Martini, A., Rabinovich, C. E. and Ruperto, N. (2011), 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: Initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis Care Res, 63: 465–482. doi: 10.1002/acr.20460
Members of the Core Expert Panel: Timothy Beukelman, MD, MSCE, Randy Q. Cron, MD, PhD, Esi Morgan DeWitt, MD, MSCE, Norman T. Ilowite, MD, Yukiko Kimura, MD, Ronald M. Laxer, MDCM, FRCPC, Daniel J. Lovell, MD, MPH, Alberto Martini, MD, C. Egla Rabinovich, MD, MPH, Nicolino Ruperto, MD, MPH.
Members of the Task Force Panel: Suzanne L. Bowyer, MD (Indiana University School of Medicine, Indianapolis), Pavla Dolezalova, MD, PhD (Charles University, Prague, Czech Republic), Ciaran M. Duffy, MBBCh, MSc (McGill University, Montreal, Quebec, Canada), James P. Guevara, MD, MPH (Children's Hospital of Philadelphia, Philadelphia, PA), Anne Murphy, PhD (University of California, San Diego), Murray H. Passo, MD (Medical University of South Carolina, Charleston), Marilynn Punaro, MD (University of Texas Southwestern, Dallas), Rayfel Schneider, MBBCh, FRCPC (University of Toronto and Hospital for Sick Children, Toronto, Ontario, Canada), David D. Sherry, MD (Children's Hospital of Philadelphia, Philadelphia, PA), Earl D. Silverman, MD, FRCPC (University of Toronto and Hospital for Sick Children, Toronto, Ontario, Canada), Janalee Taylor, RN, MSN, CPNP (Cincinnati Children's Hospital Medical Center, Cincinnati, OH), Carol A. Wallace, MD (Seattle Children's Hospital Medical Center, Seattle, WA).
Members of the University of Alabama at Birmingham Working Group: Sheree Carter, RN, MSN, Jeffrey R. Curtis, MD, MPH, Archana Jain, MD, Amy Mudano, MPH, Pongthorn Narongroeknawin, MD.
Members of the University of North Carolina at Chapel Hill Working Group: Rachel Fesperman, MD, MPH, Bethany Koestner, MSLS, Lynne Morris, MLS, Karen Rusak, MD, MPH.
American College of Rheumatology Board of Directors Liaison: Raphael Hirsch, MD (University of Pittsburgh, Pittsburgh, PA).
The American College of Rheumatology is an independent professional, medical, and scientific society which does not guarantee, warrant, or endorse any commercial product or service.
- Issue published online: 30 MAR 2011
- Article first published online: 30 MAR 2011
- Manuscript Accepted: 6 DEC 2010
- Manuscript Received: 29 JUN 2010
- American College of Rheumatology
- University of Alabama at Birmingham Deep South Musculoskeletal Center for Education and Research on Therapeutics (Agency for Healthcare Research and Quality. Grant Number: U18-HS016956
- NIH. Grant Number: 5KL2-RR025776-03
- University of Alabama at Birmingham Center for Clinical and Translational Science
Additional Supporting Information may be found in the online version of this article.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.